MiR-138-5p reverses gefitinib resistance in non-small cell lung cancer cells via negatively regulating G protein-coupled receptor 124

Biochemical and Biophysical Research Communications

Volumn 446, Issue 1, 2014, Pages 179-186

  Gao, Yi ^a   Fan, Xiaowu ^a   Li, Weina ^a   Ping, Wei ^a   Deng, Yu ^a   Fu, Xiangning ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

G protein coupled receptors; Gefitinib resistance; MicroRNA; Non small cell lung cancer; Tyrosine kinase inhibitor

Indexed keywords

G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 124; GEFITINIB; MESSENGER RNA; MICRORNA; MICRORNA 138-5P; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ARTICLE; CANCER RESISTANCE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA SEQUENCE; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IC 50; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; WESTERN BLOTTING;

G PROTEIN-COUPLED RECEPTORS; GEFITINIB RESISTANCE; MICRORNA; NON-SMALL CELL LUNG CANCER; TYROSINE KINASE INHIBITOR;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; GENE KNOCKDOWN TECHNIQUES; HUMANS; LUNG NEOPLASMS; MICRORNAS; QUINAZOLINES; RECEPTORS, G-PROTEIN-COUPLED; RNA, MESSENGER; RNA, NEOPLASM;

EID: 84898002784     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.02.073     Document Type: Article

References (29)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics CA Cancer J. Clin. 62 2012 10 29
2. T.J. Lynch, D.W. Bell, and R. Sordella Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib N. Engl. J. Med. 350 2004 2129 2139
3. K. Takezawa, V. Pirazzoli, and M.E. Arcila HER2 amplification: a potential mechanism of acquired resistance to EGFR inhibition in EGFR-mutant lung cancers that lack the second-site EGFRT790M mutation Cancer Discov. 2 2012 922 933
4. D.P. Bartel microRNAs genomics, biogenesis, mechanism, and function Cell 116 2004 281 297
5. M. Garofalo, G. Romano, and G.D. Leva EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers Nat. Med. 18 2012 74 82
6. J.A. Engelman, T. Mukohara, and K. Zejnullahu Allelic dilution obscures detection of a biologically significant resistance mutation in EGFR-amplified lung cancer J. Clin. Invest. 116 2006 2695 2706
7. C. Yamamoto, Y. Basaki, and A. Kawahara Loss of PTEN expression by blocking nuclear translocation of EGR1 in gefitinib-resistant lung cancer cells harboring epidermal growth factor receptor-activating mutations Cancer Res. 70 2010 8715 8725
8. L. Ju, C. Zhou, and W. Li Integrin beta1 over-expression associates with resistance to tyrosine kinase inhibitor gefitinib in non-small cell lung cancer J. Cell. Biochem. 111 2010 1565 1574
9. K. Shien, T. Ueno, and K. Tsukuda Knockdown of the epidermal growth factor receptor gene to investigate its therapeutic potential for the treatment of non-small-cell lung cancers Clin. Lung Cancer 13 2012 488 493
10. C. Willmore-Payne, J.A. Holden, and L.J. Layfield Detection of EGFR- and HER2-activating mutations in squamous cell carcinoma involving the head and neck Mod. Pathol. 19 2006 634 640
11. Y. Deng, J. Wang, and G. Wang P55PIK transcriptionally activated by MZF1 promotes colorectal cancer cell proliferation Biomed. Res. Int. 2013 2013
12. W. Ping, W.Y. Jiang, and W.S. Chen Expression and significance of hypoxia inducible factor-1α and lysyl oxidase in non-small cell lung cancer Asian Pac. J. Cancer Prev. 14 2013 3613 3618
13. W. Pao, V.A. Miller, and K.A. Politi Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain PLoS Med. 2 2005 225 235
14. J. Bean, C. Brennan, and J.Y. Shih MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib Proc. Natl. Acad. Sci. USA 104 2007 20932 20937
15. R. Lappano, and M. Maggiolini G protein-coupled receptors: novel targets for drug discovery in cancer Nat. Rev. Drug Discov. 10 2011 47 60
16. N. Kuzumaki, A. Suzuki, and M. Narita Multiple analyses of G-protein coupled receptor (GPCR) expression in the development of gefitinib-resistance in transforming non-small-cell lung cancer PLoS ONE 7 2012
17. F. Kuhnert, M.R. Mancuso, and A. Shamloo Essential regulation of CNS angiogenesis by the orphan G protein-coupled receptor GPR124 Science 330 2010 985 989
18. K.D. Anderson, L. Pan, and X.M. Yang Angiogenic sprouting into neural tissue requires Gpr124, an orphan G protein-coupled receptor Proc. Natl. Acad. Sci. USA 108 2011 2807 2812
19. M. Cullen, M.K. Elzarrad, and S. Seaman GPR124, an orphan G protein-coupled receptor, is required for CNS-specific vascularization and establishment of the blood-brain barrier Proc. Natl. Acad. Sci. USA 108 2011 5759 5764
20. H. Hayakawa, E. Ichihara, and K. Ohashi Lower gefitinib dose led to earlier resistance acquisition before emergence of T790M mutation in epidermal growth factor receptor-mutated lung cancer model Cancer Sci. 104 2013 1440 1446
21. M. Seike, A. Goto, and T. Okano MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers Proc. Natl. Acad. Sci. USA 106 2009 12085 12090
22. S. Mitomo, C. Maesawa, and S. Ogasawara Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines Cancer Sci. 99 2008 280 286
23. L. Jiang, Y. Dai, and X. Liu Identification and experimental validation of G protein alpha inhibiting activity polypeptide 2 (GNAI2) as a microRNA-138 target in tongue squamous cell carcinoma Hum. Genet. 129 2011 189 197
24. W. Wang, L.J. Zhao, and Y.X. Tan MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma Carcinogenesis 33 2012 1113 1120
25. X. Liu, L. Jiang, and A. Wang microRNA-138 suppresses invasion and promotes apoptosis in head and neck squamous cell carcinoma cell lines Cancer Lett. 286 2009 217 222
26. M.C. Lagerstrom, and H.B. Schioth Structural diversity of G protein-coupled receptors and significance for drug discovery Nat. Rev. Drug Discov. 7 2008 339 357
27. L. Yang, G. Chen, and S. Mohanty GPR56 Regulates VEGF production and angiogenesis during melanoma progression Cancer Res. 71 2011 5558 5568
28. F. Ciardiello, R. Caputo, and R. Caputo Antitumor activity of ZD6474, vascular endothelial growth factor receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to antiepidermal growth factor receptor therapy Clin. Cancer Res. 10 2004 784 793
29. D.L. Wheeler, E.F. Dunn, and P.M. Harari Understanding resistance to EGFR inhibitors-impact on future treatment strategies Nat. Rev. Clin. Oncol. 7 2010 493 507